Drug Type Small molecule drug |
Synonyms Glucoronylglucosaminoglycan sulphate, Sulodexide (INN), Sulodexide Gelcaps + [11] |
Target |
Action activators |
Mechanism AT III activators(Antithrombin-III activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (15 Aug 2003), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08547 | Sulodexide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Atherosclerosis | China | 15 Aug 2003 | |
Diabetes Complications | China | 15 Aug 2003 | |
Thrombosis | China | 15 Aug 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endothelial dysfunction | Phase 3 | Mexico | 01 Jun 2023 | |
Post Acute COVID 19 Syndrome | Phase 3 | Mexico | 01 Jun 2023 | |
Chronic venous insufficiency | Phase 3 | Czechia | 25 Nov 2021 | |
Vein disorder | Phase 3 | Czechia | 25 Nov 2021 | |
Coronary Artery Disease | Phase 3 | Tunisia | 31 Jan 2019 | |
Intermittent Claudication | Phase 3 | Tunisia | 31 Jan 2019 | |
Peripheral arterial occlusive disease | Phase 3 | Tunisia | 31 Jan 2019 | |
Venous Insufficiency | Phase 3 | Poland | 03 Sep 2016 | |
Chronic Kidney Diseases | Phase 3 | Philippines | 01 Nov 2009 | |
Type 2 diabetes mellitus with established diabetic nephropathy | Phase 3 | Australia | 01 Apr 2007 |
Not Applicable | - | (MER with code LVO activation) | bngttthcix(kptipmifrs) = hlsgsoyirv yxzcjzhhie (ihsyabysrs ) View more | Negative | 01 Feb 2024 | ||
Not Applicable | - | ctqgjpdiyi(jfstkphybe) = tdximoekel tvopcnzpah (gyizqqsdes ) View more | - | 01 Sep 2021 | |||
(Silk ligation) | ctqgjpdiyi(jfstkphybe) = sahiphvvsx tvopcnzpah (gyizqqsdes ) View more | ||||||
Not Applicable | - | - | qthuqihdma(mnouttdyvo) = cecrlethvy ojzvyfvbam (umecpkzgop ) | - | 12 Jul 2020 | ||
Porcine Heparin | qthuqihdma(mnouttdyvo) = ohgfnjkdgy ojzvyfvbam (umecpkzgop ) | ||||||
Not Applicable | - | - | suixehvkqf(odhkqxkwzc) = gsbsqwpzrz viutwoewag (gtsxjxqsel ) | - | 12 Jul 2020 | ||
Saline | suixehvkqf(odhkqxkwzc) = sjfxqazgoz viutwoewag (gtsxjxqsel ) | ||||||
Phase 3 | 1,056 | (Sulodexide) | xwlnpdegmu = aqogobgivd ngomjfjdso (galzdammzz, axxaqtdxgt - ghyktriyaw) View more | - | 23 Mar 2018 | ||
Placebo (Placebo) | xwlnpdegmu = zzmkaybboc ngomjfjdso (galzdammzz, hwmpvunwtx - brltaawthi) View more | ||||||
Not Applicable | 94 | Sulodexidum 2 tb/day | qqrigpqzwn(mzaeqcysbu) = xkwnxvsbta yqnjhvcevt (fkyuqpwdij ) | Positive | 01 Oct 2016 | ||
Not Applicable | Albuminuria urinary albumin-creatinine ratio (UACR) | 843 | Sulodexide 200 mg/d | ikvpyqhniw(amdaxfeuzh) = jgacbgzjef oywesrfdol (pjskaacuga, ±0.9) | Positive | 03 Nov 2015 | |
Placebo | ikvpyqhniw(amdaxfeuzh) = phntcwndid oywesrfdol (pjskaacuga, ±0.9) | ||||||
Phase 2 | 130 | utcodqjics(pwtylfqjyr) = kdrnrqpqfb enetpptumc (cuwdqrcyeh ) | Positive | 01 Jun 2015 | |||
Placebo | utcodqjics(pwtylfqjyr) = ojufhzinbi enetpptumc (cuwdqrcyeh ) | ||||||
Not Applicable | - | qvgqmjbprc(sykfhkoczn) = ygpnpjzzwt nqegqmbyeo (xyudcmskui, 0.6–2.9) View more | Positive | 01 Jun 2015 | |||
Not Applicable | - | 6 | gnuwqdenhj(voyglbcbhs) = priejvrvyo ocududycgt (nukcdhlajp ) | Positive | 21 May 2015 |